The impact of injuries extends beyond the individual athlete to the larger team framework. Cubarsí’s sidelining could pose challenges for the Spanish national team as they traverse the upcoming ...

The 17-year-old suffered a grade 1 anterior tibiofibular ligament injury during Sunday's match against Leganés, impacting his contributions to the team. Barcelona winger Lamine Yamal will be ...

Pau Cubarsí’s lack of minutes in the match was more than just a tactical decision; it was a response to pain and discomfort. Following the game, it was confirmed that Cubarsí suffered a strain in the ...

The tests revealed that the player has a strain in the anterior tibiofibular ligament of his right ankle. Cubarsí will follow a conservative treatment plan, and his tolerance to activity will be ...

“Pau Cubarsi has an elongation of the anterior tibiofibular ligament in his right ankle,” the club said. “He will undergo conservative treatment, and his tolerance to activity will be re-eva ...

The tests revealed that the player has a strain in the anterior tibiofibular ligament of his right ankle. Cubarsí will follow a conservative treatment plan, and his tolerance to activity will be ...

Barcelona and the RFEF were at odds not too long ago over the situation of Pau Cubarsi and the next steps to be taken after ...

The young sensation is sidelined for three to four weeks due to a Grade 1 injury to the anterior tibiofibular ligament in his right ankle, as confirmed by the club's medical team earlier this week.

The club's report states that "the tests conducted this morning at the Ciutat Esportiva Joan Gamper have shown that first-team player Pau Cubarsí has an elongation of the anterior tibiofibular ...

Barcelona will leave a final fitness decision on Pau Cubarsi until just before their La Liga clash with Osasuna on March 27.La Blaugrana return to action in their rearranged game on home soil ...

Reports from Marca highlight that Cubarsi has suffered a ‘strain in the anterior tibiofibular ligament of his right ankle’ and will continue with treatment in the coming days. Cubarsi will be ...